Pharmacology Captopril

Download as pptx, pdf, or txt
Download as pptx, pdf, or txt
You are on page 1of 14

PHARMACOLOGY & IMMUNOLOGY

MWMS 4023
ANTI-HYPERTENSIVE DRUGS
(CAPTOPRIL)

KUMPULAN 4
1.SALMIZA BINTI DARUS ADMW1/2024(03)-0025
2.ASMARIA BINTI IBRAHIM ADMW1/2024(03)-0001
3.NOR DALILA BINTI ARSHAD ADMW1/2024(03)-0013
4.NOR AIN BINTI MOHD YUSOF ADMW1/2024(03)-0012
5.FADILAH BINTI MUSTAPA ADMW1/2024(03)-0003
1
Learning Outcome:

1. Explain pharmacokinectics and pharmacodynamics


of Anti-hypertensive drugs.
 Dosage
 Route
 Frequency
 Indication
 Contraindication
 Side effect.
 Care before giving medication 2

 Care after giving medication


ANGIOTENSIN CONVERTING ENZYME -
CAPTOPRIL

 TRADE NAME = CAPTOPRIL


 BRAND NAME = CAPOTEN
 CLASS = ACE INHIBITORS

3
INTRODUCTION
 Captoprilis a medication used to treat high blood
pressure,congestive heart failure,and kidney
problems caused by diabetes.
 Itbelongs to a class of drugs called angiotensin-
converting enzyme (ACE) inhibitors,with work by
blocking the production of a hormone called
angiotensin II,with causes blood vessels to
constrict.
4
Indication:
 Hypertension
 Congestive heart failure.
 Post myocardial infarction.
 Diabetic nepropathy

Contraindication:
 Angiotensin-converting enzyme (ACE) inhibitors are contraindicated during second and third
trimester of pregnancy, drug may cause fetal injury and death. Discontinue as soon
as possible when pregnancy is detected.
 Lactation
 Hypersensitivity to drug or others ACE inhibitors.
 Bilateral renal artery stenosis
 Allergy to captopril,history of angioedema
5
(References : DIMS and Rnpedia.com)
Pharmacokinetics:
 Metabolism: 50% is metabolized in the liver.
 Absorption: Rapidly absorbed from the gastrointestinal tract.
 Distribution: Distributed into most body tissues also crosses
placenta and enters breast milk (small amounts).
 Excretion: Via urine and small amounts are excreated in feces.

6
Pharmacodynamic:
 Inhibits ACE needed to convert inactive angiotensin I to active angiotensin II

Captopril prevents the conversion of angiotensin I to


angiotensin II by inhibiting ACE

Reduces plasma angiotensin II

Increasing plasma renin activity (PRA) due to loss of


negative feedback and release renin

Aldosterone decreases

reducing sodium and water retention and lowering


blood pressure.
7
DOSAGE
 Hypertension
-Initial : 12.5mg BD
-Maintenance: 25-50mg BD
-Max : 50mg TDS

 Heart failure
-Initial : 6.25mg-12.5mg 2-3 times/day
-Max : 50mg TDS

 Diabetic nephropathy 25mg tds

ROUTE
 Per oral

FREQUENCY 8

 8-12 hours
9
SIDE EFFECT
 Hypotension
 Hypersensetivity
 Cough – Caused by Bradycinin and substance accumulates above and below
and obstructed/blocked airways by ACE I enzyme.
 Nausea
 Chest pain
 Palpitation
 Tachycardiac
 Proteinuria
 Flushing (sudden warmth, redness, or tingly feeling)

10
(References: DIMS)
CARE BEFORE GIVING MEDICATION
 Prepare the necessary equipment
 Make sure the patients is not taking other drug that interact with
this drug.
 Given medicine 1 hour before meals
 Stop antihypertensive medication 1 week before starting captopril
 Practice “7 R”
(Right patient,right drug,right dose,right time,right route,right to
refuse,right documentation.)

11
CARE AFTER GIVING MEDICATION

• Check vital sign especially blood pressure every 15minute for 1


hour,then hourly.
• Monitor drug side effects : hypotension
• Report to doctor if any abnormality
• Document all information obtained

12
ASSESSMENT
 Monitor for sudden blood pressure drop within 3 hours of
initial dose if patient is receiving concurrent diuretics and
a low-sodium diet.
 Tellpatient to take drug 1 hour before meals on empty
stomach.
 Advise patient to report fever, rash, sore throat and cough.
 Inform patient that dizziness, fainting and light-
headedness usually disappear once his body adjust to drug.

13
REFERENCES

 Wolters k, willium L. and wilkin 2009.Nursing Pharmacology made Increadibly.


 Mosby’s Drug Guideline for Nurses .2009.ed 8
 https://www.mayoclinic.org
 www.npra.gov.my
 Nursing spectrum drug hand book/patricia dwyer schull
 Clinical practice guidelines management of hypertension 5th edition(2018)
 Reference.Medscape.com/drug
 Drug and nursing implications 8th edition (Shannon,Wilson,stang)
 Clinical practice guidelines 5th edition 2018
 https://www.medicinenet.com/labetalol/article.htm
 https://www.webmd.com/drugs/2/drug-7212/labetalol-oral/details

14

You might also like